Covestro is collaborating with PharmaJet over needle-free injection technology.
The PharmaJet systems require a polycarbonate material to meet the specifications of the syringe and vial adapter while standing up to gamma radiation and ethylene oxide sterilisation, with Covestro supporting PharmaJet’s material needs.
“We needed a polycarbonate resin that was suitable for our biotech applications and came from a vendor we could rely on,” said Chris Cappello, president and CEO, at PharmaJet. “Covestro has provided great support to PharmaJet in the fight against COVID-19, allowing the collaboration to achieve better immunological results than needle and syringe delivery.”